Dutch-based Leyden Labs gets €20M EIB backing to protect against influenza outbreaks, including avian flu
Dutch-based Leyden Laboratories BV, a clinical-stage biotech company, announced that it has signed a €20M venture debt financing from the European Investment Bank (EIB).